Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Inhibition of apoptosis by miR‑122‑5p in α‑fetoprotein‑producing gastric cancer.

Maruyama S, Furuya S, Shiraishi K, Shimizu H, Saito R, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D.

Oncol Rep. 2019 Apr;41(4):2595-2600. doi: 10.3892/or.2019.7023. Epub 2019 Feb 20.

PMID:
30816512
2.

Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.

Jia Y, Liu D, Xiao D, Ma X, Han S, Zheng Y, Sun S, Zhang M, Gao H, Cui X, Wang Y.

PLoS One. 2013;8(1):e54774. doi: 10.1371/journal.pone.0054774. Epub 2013 Jan 30.

3.

Possible involvement of persistent activity of the mammalian target of rapamycin pathway in the cisplatin resistance of AFP-producing gastric cancer cells.

Kamata S, Kishimoto T, Kobayashi S, Miyazaki M, Ishikura H.

Cancer Biol Ther. 2007 Jul;6(7):1036-43.

PMID:
17568186
4.

miR-122-5p as a novel biomarker for alpha-fetoprotein-producing gastric cancer.

Maruyama S, Furuya S, Shiraishi K, Shimizu H, Akaike H, Hosomura N, Kawaguchi Y, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D.

World J Gastrointest Oncol. 2018 Oct 15;10(10):344-350. doi: 10.4251/wjgo.v10.i10.344.

5.

Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.

He R, Yang Q, Dong X, Wang Y, Zhang W, Shen L, Zhang Z.

Oncotarget. 2017 Apr 4;8(14):23817-23830. doi: 10.18632/oncotarget.15909.

6.

Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.

Gong W, Su Y, Liu A, Liu J, Sun D, Jiang T, Xiang J, Chi C, Sun P.

Neoplasma. 2018 Mar 14;65(3):326-330. doi: 10.4149/neo_2018_170207N84.

PMID:
29788728
7.

Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.

Li XD, Wu CP, Ji M, Wu J, Lu B, Shi HB, Jiang JT.

World J Surg Oncol. 2013 Oct 1;11:246. doi: 10.1186/1477-7819-11-246. Review.

8.

Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.

Arakawa Y, Tamura M, Aiba K, Morikawa K, Aizawa D, Ikegami M, Yuda M, Nishikawa K.

Oncol Lett. 2017 Sep;14(3):3039-3042. doi: 10.3892/ol.2017.6514. Epub 2017 Jun 30.

10.

[AFP-producing gastric cancer and hepatoid gastric cancer].

Wang YK, Zhang XT.

Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):801-807. doi: 10.3760/cma.j.issn.0253-3766.2017.11.001. Chinese.

PMID:
29151285
11.

Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.

Qiao F, Gong P, Song Y, Shen X, Su X, Li Y, Wu H, Zhao Z, Fan H.

Cell Physiol Biochem. 2018;46(6):2215-2231. doi: 10.1159/000489590. Epub 2018 May 3.

12.

Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines.

Tokita H, Tsuchida A, Miyazawa K, Ohyashiki K, Katayanagi S, Sudo H, Enomoto M, Takagi Y, Aoki T.

Int J Mol Med. 2006 Feb;17(2):235-43.

PMID:
16391821
13.

HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.

Fujimoto M, Matsuzaki I, Nishino M, Iwahashi Y, Warigaya K, Kojima F, Ono K, Murata SI.

J Clin Pathol. 2018 Jul;71(7):600-607. doi: 10.1136/jclinpath-2017-204928. Epub 2018 Jan 5.

PMID:
29305518
14.
15.

Upregulation of miR‑185 promotes apoptosis of the human gastric cancer cell line MGC803.

Fan L, Tan B, Li Y, Zhao Q, Yuan H, Liu Y, Wang D, Zhang Z.

Mol Med Rep. 2018 Feb;17(2):3115-3122. doi: 10.3892/mmr.2017.8206. Epub 2017 Dec 6.

PMID:
29257260
16.

Double cancer of the stomach, one AFP-producing tumor.

Hyodo T, Kawamoto R.

J Gastroenterol. 1996 Dec;31(6):851-4.

PMID:
9027651
17.
18.

Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases.

Fang YU, Wang L, Yang N, Gong X, Zhang YU, Qin S.

Oncol Lett. 2015 Nov;10(5):3021-3025. Epub 2015 Sep 21.

19.

Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.

Reim D, Choi YS, Yoon HM, Park B, Eom BW, Kook MC, Ryu KW, Choi IJ, Joo J, Kim YW.

Eur J Surg Oncol. 2017 Aug;43(8):1542-1549. doi: 10.1016/j.ejso.2017.04.005. Epub 2017 May 3.

PMID:
28511775
20.

In vitro model of suicide gene therapy for alpha-fetoprotein-producing gastric cancer.

Nakaya H, Ishizu A, Ikeda H, Tahara M, Shindo J, Itoh R, Takahashi T, Asaka M, Ishikura H, Yoshiki T.

Anticancer Res. 2003 Sep-Oct;23(5A):3795-800.

PMID:
14666679

Supplemental Content

Support Center